Biography
I am research director at the National Institute of Health and Medical Research (INSERM). I am a team leader at the OncoLille cancer research Institute located in the Lille university hospital. My team study the receptor tyrosine kinases (RTK), mainly the MET receptor, and their downstream signaling pathways including the transcriptional integration of the signaling. Our main object is to improve efficacy of the targeted therapies directed against RTK notably in lung and prostate cancers.
Research Interest
Cancer, Receptor tyrosine kinase, Intracellular signaling, tumor suppressor genes, Survival/apoptosis balance, Transcriptional regulation, lung Cancer, Targeted therapies, Resistance